Antimicrobial Resistance Surveillance among Nosocomial Pathogens in South Africa: Systematic Review of Published Literature

References 

1. Goering R, Nord CE, Hare R, Sabatelli F. Ziracin susceptibility testing group. In vitro activity of evernimicin and selected antibiotics against methicillin-resistant staphylococci: a 24-country study. Clin Microbiol Infect. 2000;6:549–556
   • CrossRef
2. Jeena P, Thompson E, Nchabeleng M, Sturm A. Emergence of multi-drug-resistant Acinetobacter anitratus species in neonatal and paediatric intensive care units in a developing country: concern about antimicrobial policies. Ann Trop Paediatr. 2001;21:245–251
   • MEDLINE
   • CrossRef
3. Roca A, Quinto L, Abacassamo F, Morais L, Valles X, Espasa M, et al Invasive Haemophilus influenzae disease in children less than 5 years of age in Manhica, a rural area of southern Mozambique. Trop Med Int Health. 2008;13:818–826
   • CrossRef
4. Sigauque B, Roca A, Sanz S, Oliveiras I, Martínez M, Mandomando I, et al Acute bacterial meningitis among children, in Manhica, a rural area in southern Mozambique. Acta Trop. 2008;105:21–27
   • CrossRef
5. Shapiro RL, Kumar L, Phillips-Howard P, Wells JG, Adcock P, Brooks J, et al Antimicrobial-resistant bacterial diarrhea in rural western Kenya. J Infect Dis. 2001;183:1701–1704
6. Klugman KP. Emerging infectious diseases—South Africa. Emerg Infect Dis. 1998;4:517–520
   • MEDLINE
7. Marais E, Aithma N, Perovic O, Oosthuysen WF, Musenge E, Duse AG. Antimicrobial susceptibility of methicillin-resistant Staphylococcus aureus isolates from South Africa. S Afr Med J. 2009;99:170–173
8. The European Antimicrobial Resistance Surveillance System. EARSS manual. 2005. Available from: http://www.rivm.nl/earss/. [accessed 10.01.10].
9. Naude duT E, Van den Ende J, Botha P, Forder A, Hyland J, de Klerk HC, et al A multicentre study on the susceptibility of a variety of bacteria to cephalothin, cefamandole, tobramycin and gentamicin. S Afr Med J. 1977;52:798–800
10. Van den Ende J, Rotter MI. An analysis of blood culture isolates from 7 South African teaching hospital centres. S Afr Med J. 1986;69:89–93
11. Antibiotic Study Group of South Africa . Number of isolates and antibiotic resistance from seven academic training hospitals in South Africa. S Afr Med J. 1986;80:366
12. Antibiotic Study Group of South Africa . Susceptibility of invasive pathogens from academic in hospitals in South Africa to selected antimicrobial agents. South Afr J Epidemiol Infect. 2000;15:51–55
13. Mocktar C, Govinden U, Sturm AW, Essack S. Complexity and diversity of beta-lactamase expression in inhibitor-resistant Escherichia coli from public hospitals in KwaZulu-Natal, South Africa. South Afr J Epidemiol Infect. 2009;24:29–33
14. Nel H, van Vuuren M, Swan GE. Towards the establishment and standardization of a veterinary antimicrobial resistance surveillance and monitoring programme in South Africa. Onderstepoort J Vet Res. 2004;71:239–246
    • MEDLINE
15. Holloway K, Mathai E, Gray A, Chandy S, Essack SY, Gous A, et al Surveillance of antimicrobial resistance in resource-constrained settings—experience from five pilot projects. Trop Med Int Health. 2011;16:368–374
    • CrossRef
16. Bamford C, Badenhorts I, Duse AG, Hoosen AA, Oliver S, Perovic O, et al Antimicrobial susceptibility patterns of selected invasive pathogens from public sector hospitals in South Africa. South Afr J Epidemiol Infect. 2007;2009(24):28–30
17. Brink A, Moolman J, da Silva MC, Botha M. National Antibiotic Surveillance Forum. Antimicrobial susceptibility profile of selected bacteraemic pathogens from private institutions in South Africa. S Afr Med J. 2007;97:273–279
18. Crewe-Brown HH, Coovadia Y, Dove MG, Hanslo D, Hoosen AA, Kooornhof HJ, et al Susceptibility of invasive pathogens from academic in hospitals in South Africa to selected antimicrobial agents for the year 2000. South Afr J Epidemiol Infect. 2001;16:91–95
19. Sein PP, Hoosen AA, Crewe-Brown HH, Coovadia Y, Dove MG, Heidi O, et al Antimicrobial susceptibility profile of selected invasive pathogens from academic in hospitals in South Africa for the year 2001–2004. South Afr J Epidemiol Infect. 2005;20:85–89
20. Liebowitz LD, Slabbert M, Huisamen A. National surveillance programme on susceptibility patterns of respiratory pathogens in South Africa: moxifloxacin compared with eight other antimicrobial agents. J Clin Pathol. 2003;56:344–347
21. Essack SY, Connolly C, Sturm WA. Antibiotic use and resistance in public-sector hospitals in KwaZulu-Natal. S Afr Med J. 2005;95:865–870
22. National Antimicrobial Surveillance Forum . Surveillance data: National antimicrobial surveillance forum—private susceptibility data July–December 2007. South Afr J Epidemiol Infect. 2008;23:44–48
23. Essack SY. Unprecedented resistance to B-lactam antibiotics evident in Durban, South Africa—surveillance-based antibiotic policies imperative!. South Afr J Epidemiol Infect. 2000;15:48–50
24. Perovic O, Koornhof HJ, Crewe-Brown HH, Duse AG, van Nierop W, Galpin JS. Pseudomonas aeruginosa bacteraemia in an academic hospital in South Africa. S Afr Med J. 2008;98:626–632
25. Vlieghe E, Phoba MF, Tamfun JJM, Jacobs J. Antibiotic resistance among bacterial pathogens in Central Africa: a review of the published literature between 1955 and 2008. Int J Antimicrob Agents. 2009;34:295–303
    • Abstract
    • Full Text
    • Full-Text PDF (490 KB)
    • CrossRef